“Anal%2Bcancer”的搜索结果，显示 21-30 项，共有 5738 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   :Cohort 1 includes (1) advanced unresectable pancreatic cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative ...

2. 神经科- 临床试验- 妙佑医疗国际

   :Cohort 1 includes (1) advanced unresectable pancreatic cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative ...

3. 乳腺癌- 医生与科室- 妙佑医疗国际

   Bone marrow transplant, Breast cancer, Cancer, Ovarian cancer, Gynecologic cancer ... 2B. 显示更多擅长领域 针对Patricia A. Cronin, M.D. ... Go to page 22 ...

4. Mayo Clinic Cancer Physician Update - July 2022

   Page 1.

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Scottsdale/Phoenix, Ariz. The purpose of this study is to examine the needs and gap in our understanding of financial burden experienced by rectal cancer ...

6. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers. Rochester, Minn. A Phase 1b/2, open label, multi- ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   :Cohort 1 includes (1) advanced unresectable pancreatic cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objectives of this study are to determine the maximum tolerated dose/recommended phase 2 dose (MTD/RP2D) of selumetinib + vinblastine for ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... rectal cancer that has spread to other places in the body (advanced). ... 2 (HER2). HER2 is found on some cancer cells ... tumor cell may be marked for destruction ...

10. 血液科- 临床试验- 妙佑医疗国际

    :Cohort 1 includes (1) advanced unresectable pancreatic cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative ...